CO-TRIMOXAZOLE 24%

Sulfamethoxazole 200 mg

Trimethoprim 40 mg

Excipients up to 1 ml
Composition
Infections of the respiratory tract, gastro-intestinal tract, and urogenital tract, infections of skin, soft tissue and wounds and septicaemia. Indications
Haematopoietic, renal and hepatic disturbances.

The intravenous route of administration is contra-indicated in the case of previous or concurrent administration of central nervous system depressants (e.g.anaesthetics,neuroleptics)
Contraindications
Transient local reactions (swelling .pain) at the site of injection may occur.

Allergic reactions(e.g. polyarthritis, keratoconjunctivitis sicca, erythrema in dogs) seldom occur.

Cardiac and respiratory shock have been observed after intravenous administration (particularly in horses).
Adverse reactions
By deep intramuscular, subcutaneous or slow intravenous injection.

24 mg/kg b.w. or 1 ml/10kg b.w once daily or divided over 2 administrations with 12 hours intervals. Treatment should be continued up to 1-2 days after disappearance of clinical symptoms.
Administration & dosage
Meat: 5 days

Milk: 3 days
Withdrawal period
Protect from light and heat. Storage
100 ml. Packaging
KELA Laboratoria N.V - Belgium. Manufacturer